1. Home
  2. CASH vs LGND Comparison

CASH vs LGND Comparison

Compare CASH & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASH
  • LGND
  • Stock Information
  • Founded
  • CASH 1954
  • LGND 1987
  • Country
  • CASH United States
  • LGND United States
  • Employees
  • CASH N/A
  • LGND N/A
  • Industry
  • CASH Major Banks
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • CASH Finance
  • LGND Health Care
  • Exchange
  • CASH Nasdaq
  • LGND Nasdaq
  • Market Cap
  • CASH 1.9B
  • LGND 2.0B
  • IPO Year
  • CASH N/A
  • LGND 1992
  • Fundamental
  • Price
  • CASH $78.05
  • LGND $102.19
  • Analyst Decision
  • CASH Buy
  • LGND Strong Buy
  • Analyst Count
  • CASH 2
  • LGND 8
  • Target Price
  • CASH $92.00
  • LGND $144.71
  • AVG Volume (30 Days)
  • CASH 158.7K
  • LGND 118.3K
  • Earning Date
  • CASH 07-23-2025
  • LGND 05-08-2025
  • Dividend Yield
  • CASH 0.26%
  • LGND N/A
  • EPS Growth
  • CASH 10.71
  • LGND N/A
  • EPS
  • CASH 7.36
  • LGND N/A
  • Revenue
  • CASH $731,383,000.00
  • LGND $181,488,000.00
  • Revenue This Year
  • CASH $13.95
  • LGND $17.68
  • Revenue Next Year
  • CASH $5.74
  • LGND $18.69
  • P/E Ratio
  • CASH $10.61
  • LGND N/A
  • Revenue Growth
  • CASH 6.51
  • LGND 53.40
  • 52 Week Low
  • CASH $51.98
  • LGND $77.43
  • 52 Week High
  • CASH $86.00
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • CASH 47.77
  • LGND 44.63
  • Support Level
  • CASH $76.98
  • LGND $98.90
  • Resistance Level
  • CASH $78.77
  • LGND $103.17
  • Average True Range (ATR)
  • CASH 1.69
  • LGND 3.05
  • MACD
  • CASH -0.66
  • LGND -0.27
  • Stochastic Oscillator
  • CASH 18.38
  • LGND 31.94

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: